HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Bactericidal activity of gatifloxacin (AM-1155) against Pseudomonas aeruginosa and Enterococcus faecalis in an in vitro bladder model simulating human urinary concentrations after oral administration.

Abstract
The bactericidal activity of gatifloxacin, a new 6-fluoro-8-methoxy quinolone, was determined in a dynamic in vitro model mimicking complicated lower urinary tract infection. Strains of Pseudomonas aeruginosa and Enterococcus faecalis with different susceptibility were exposed to changing gatifloxacin concentrations, simulating human urinary concentrations afer oral treatment with 200 mg twice daily for 3 consecutive days. Bacterial numbers of P. aeruginosa (minimal inhibitory concentrations, MIC: < or =32 microg/ml) and of E. faecalis (MIC: 16 microg/ml) were reduced to undetectable levels during exposure. For the strains with lower susceptibility, gatifloxacin showed bactericidal activity, but eradication was not complete. Thus, in a complicated urinary tract infection model, breakpoint MICs of gatifloxacin for uropathogenic organisms were presumed to range from 16 to 32 microg/ml. At least 86% of recent clinical isolates of P. aeruginosa and E. faecalis were inhibited at its breakpoint MIC. These results suggest that gatifloxacin may be useful in the treatment of urinary tract infections.
AuthorsS Takahashi, H Ebisu, T Hirose, M Sano, M Nishimura, K Hirai, T Tsukamoto, M Hosaka
JournalChemotherapy (Chemotherapy) 2000 Mar-Apr Vol. 46 Issue 2 Pg. 122-8 ISSN: 0009-3157 [Print] SWITZERLAND
PMID10671763 (Publication Type: Journal Article)
CopyrightCopyright 2000 S. Karger AG, Basel.
Chemical References
  • Anti-Infective Agents
  • Fluoroquinolones
  • gatifloxacin
Topics
  • Administration, Oral
  • Anti-Infective Agents (administration & dosage, pharmacokinetics, urine)
  • Enterococcus faecalis (drug effects)
  • Fluoroquinolones
  • Gram-Positive Bacterial Infections (drug therapy, urine)
  • Humans
  • Models, Biological
  • Pseudomonas Infections (drug therapy, urine)
  • Pseudomonas aeruginosa (drug effects)
  • Time Factors
  • Urinary Bladder (drug effects, metabolism, microbiology)
  • Urinary Bladder Diseases (drug therapy, urine)
  • Urinary Tract Infections (drug therapy, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: